![Thomas Lynch lists his areas of emphasis at the Hutch: Solid tumors, immuno-oncology, big data, microbial involvement](https://cdn.cancerletter.com/media/2020/01/25191749/Hutch_4x3.jpg)
![Thomas Lynch lists his areas of emphasis at the Hutch: Solid tumors, immuno-oncology, big data, microbial involvement](https://cdn.cancerletter.com/media/2020/01/25191749/Hutch_4x3.jpg)
Cover Story
Conversation with The Cancer LetterFree
On Feb. 1, Thomas J. Lynch will report to work as president and director of Fred Hutchinson Cancer Research Center.
By Alexandria Carolan
By Alexandria Carolan
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
Drugs & Targets
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Lei Zheng named executive director of Mays Cancer Center
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence - NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”